Press Releases

NEW YORK , Sept. 17, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M.

NEW YORK , Sept. 13, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that that management will be ringing the Nasdaq Stock Market Opening Bell on Friday, September 14, 2018 .

- Contract Valued at Up to $629 Million – - Contract Includes Delivery of Oral and Intravenous (IV) Formulations of TPOXX; Development of IV TPOXX; Post-marketing Activities – NEW YORK , Sept. 10, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage

- First therapy specifically approved for smallpox advances health security against a significant bioterror threat- - Company Granted Priority Review Voucher - NEW YORK , July 13, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ:SIGA), a commercial-stage pharmaceutical company

- Results support the use of TPOXX to treat smallpox, a highly contagious and lethal virus that poses significant bioterror threat - NEW YORK , July 05, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ:SIGA), a commercial-stage pharmaceutical company focused on the health security

NEW YORK , May 31, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies , Inc. ( SIGA ) (NASDAQ:SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Phillip L. Gomez , SIGA’s Chief Executive Officer, will present at the Jefferies Global Healthcare

NEW YORK , May 01, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ:SIGA), a health security company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, today announced a favorable outcome of the U.S.

NEW YORK , May 01, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ:SIGA), a health security company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, today announced that Nasdaq has halted trading of the company’s

Company Also Provides Milestone Updates NEW YORK , March 20, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (Nasdaq:SIGA), a health security company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, today announced that The

- If approved, TPOXX would be the first treatment for smallpox - NEW YORK , Feb. 07, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (OTCMKTS:SIGA), a health security company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats,